SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000920465-16-000141
Filing Date
2016-11-18
Accepted
2016-11-18 17:20:55
Documents
6
Effectiveness Date
2016-11-18

Document Format Files

Seq Description Document Type Size
1 S-8 s-82016.htm S-8 112989
2 EXHIBIT 5.1 exhibit51.htm EX-5.1 9189
3 EXHIBIT 23.1 exhibit231.htm EX-23.1 3305
4 image1a02.jpg GRAPHIC 19299
5 image2.jpg GRAPHIC 11015
6 image3.jpg GRAPHIC 19284
  Complete submission text file 0000920465-16-000141.txt   178907
Mailing Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121
Business Address 10182 TELESIS COURT, 6TH FLOOR SAN DIEGO CA 92121 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-214722 | Film No.: 162008608
SIC: 2836 Biological Products, (No Diagnostic Substances)